Loading
Latest filing published 14 Nov 2018 for Arbutus Biopharma Corporation.
No signal scores available.
All filings by James Robert Meyers on record concern Arbutus Biopharma Corporation. Activity is concentrated on a single trading day, 18 October 2018, with 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 14 November 2018 with a transaction in Arbutus Biopharma Corporation. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations